Guardion Health Sciences Statistics Share Statistics Guardion Health Sciences has 1.35M
shares outstanding. The number of shares has increased by 5.12%
in one year.
Shares Outstanding 1.35M Shares Change (YoY) 5.12% Shares Change (QoQ) 0% Owned by Institutions (%) 0% Shares Floating 1.16M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 22.26K, so undefined% of the outstanding
shares have been sold short.
Short Interest 22.26K Short % of Shares Out n/a Short % of Float 1.92% Short Ratio (days to cover) 0.18
Valuation Ratios The PE ratio is 42.94 and the forward
PE ratio is -3.16.
Guardion Health Sciences's PEG ratio is
-0.43.
PE Ratio 42.94 Forward PE -3.16 PS Ratio 0.55 Forward PS 0.3 PB Ratio 0.83 P/FCF Ratio -1.55 PEG Ratio -0.43
Financial Ratio History Enterprise Valuation Guardion Health Sciences has an Enterprise Value (EV) of 426.67K.
EV / Sales 0.03 EV / EBITDA -0.11 EV / EBIT -0.1 EV / FCF -0.1
Financial Position The company has a current ratio of 9.01,
with a Debt / Equity ratio of 0.
Current Ratio 9.01 Quick Ratio 6.98 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 1.94% and Return on Invested Capital is -40.91%.
Return on Equity 1.94% Return on Assets 1.33% Return on Invested Capital -40.91% Revenue Per Employee $1.36M Profits Per Employee $17.56K Employee Count 9 Asset Turnover 1.03 Inventory Turnover 2.56
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -63.28% in the
last 52 weeks. The beta is 0.71, so Guardion Health Sciences's
price volatility has been higher than the market average.
Beta 0.71 52-Week Price Change -63.28% 50-Day Moving Average 3.22 200-Day Moving Average 5.8 Relative Strength Index (RSI) 25.77 Average Volume (20 Days) 34,154
Income Statement In the last 12 months, Guardion Health Sciences had revenue of 12.25M
and earned 158.03K
in profits. Earnings per share was 0.12.
Revenue 12.25M Gross Profit 5.39M Operating Income -4.34M Net Income 158.03K EBITDA -3.92M EBIT -3.94M Earnings Per Share (EPS) 0.12
Full Income Statement Balance Sheet The company has 6.36M in cash and 0 in
debt, giving a net cash position of 6.36M.
Cash & Cash Equivalents 6.36M Total Debt n/a Net Cash n/a Retained Earnings -93.57M Total Assets 15.3M Working Capital 14.37M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.37M
and capital expenditures -3.79K, giving a free cash flow of -4.37M.
Operating Cash Flow -4.37M Capital Expenditures -3.79K Free Cash Flow -4.37M FCF Per Share -3.44
Full Cash Flow Statement Margins Gross margin is 44.04%, with operating and profit margins of -35.4% and 1.29%.
Gross Margin 44.04% Operating Margin -35.4% Pretax Margin 1.29% Profit Margin 1.29% EBITDA Margin -32.02% EBIT Margin -35.4% FCF Margin -35.71%
Dividends & Yields GHSI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 2.33% FCF Yield -64.45%
Dividend Details Analyst Forecast Currently there are no analyst rating for GHSI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 9, 2023. It was a
forward
split with a ratio of 50:1.
Last Split Date Jan 9, 2023 Split Type forward Split Ratio 50:1
Scores Altman Z-Score -5.54 Piotroski F-Score 5
